Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Zentalis Pharmaceuticals Inc., 3 years.
Zentalis Pharmaceuticals Inc.
Director
Immuneering Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 9, 2024 | Zentalis Pharmaceuticals Inc. | Open-market sale | −3,356 | $12.62 | $42,353 |
| Feb 1, 2024 | Zentalis Pharmaceuticals Inc. | Grant or award | +337,500 | — | — |
| May 8, 2023 | Zentalis Pharmaceuticals Inc. | Grant or award | +39,732 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.